Amryt Pharma plc Earning Date (AMYT)

USA |NASDAQ |USD

AMYT Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Aug 6, 2022 (est) Jun 30, 2022 - $-0.05 $-0.04
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Aug 6, 2022 (est) Jun 30, 2022 - - $62.76M

Amryt Pharma Plc's next estimated earnings date (based on same quarter last year's date) is Aug 6, 2022 for the fiscal quarter ending Jun 30, 2022.

AMYT Earnings Date & History Chart

AMYT Earnings & Revenue Forecast

AMYT Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 3 $0.10 $0.00 $0.21

AMYT Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 0 / 0 $0.96 $1.71 $1.71

AMYT Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 5 $356.00M $263.53M $433.80M

AMYT Earnings Date & Revenue History

AMYT Earnings History

|
Show More
Show More

AMYT Revenue History

|
Show More
Show More

Amryt Pharma Plc Next Earnings Date & Report

AMYT May 2022 (FQ) Earnings Date & Report Preview

AMYT's next estimated earnings date (based on same quarter last year's report date) is Aug 6, 2022 for the fiscal quarter ending Jun 30, 2022.

Amryt Pharma Plc Previous Earnings Dates & Reports

AMYT Previous Earnings Date & Report Recap: Mar 2022 (FQ)

Amryt Pharma Plc's previous earnings date was May 4, 2022 for its fiscal quarter ended Mar 31, 2022.

AMYT's earnings per share (EPS) was $-0.05, missing the consensus analysts forecast of $-0.02 by -150.00%.

The EPS was lower than the previous fiscal quarter (Dec 2021) by -106.25%, and higher than the same period a year before (Mar 2021) by -44.44%.

AMYT Previous Earnings Date & Report Recap: Dec 2021 (FY)

Amryt Pharma Plc's previous annual earnings date was Mar 9, 2022 for its fiscal year ended Dec 31, 2021.

AMYT's earnings per share (EPS) was $0.60, beating the consensus analysts forecast of $-0.43 by -239.53% , and higher than the previous year's EPS (Dec 2020) by -142.70%.

Revenues were $222.54M, better than the forecast of $221.27M by 0.58%, and up by 21.87% from previous year's revenue.

The company reported a net income of $-18.17M.

Amryt Pharma Plc reported a free cash flow of $13.99M for its fiscal year, compared to $24.43M a year ago.

The company ended the fiscal year with $199.18M in total debt, an increase of 5.19% compared to the previous year.